Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) has received a consensus rating of “Moderate Buy” from the four analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among brokers that […]